SURELITE Trademark

Trademark Overview


On Friday, November 17, 2023, a trademark application was filed for SURELITE with the United States Patent and Trademark Office. The USPTO has given the SURELITE trademark a serial number of 79388704. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, February 9, 2024. This trademark is owned by Sansure Biotech Inc.. The SURELITE trademark is filed in the Medical Instrument Products category with the following description:

Immunochemical testing apparatus for medical use; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical diagnostic apparatus for testing blood sugar levels, cancer cells, dna and rna, antigen and antibody levels, hormones and metabolites and viruse; apparatus for DNA and RNA testing for medical purposes; analysers for medical use, namely, blood immunoassay analysers, enzyme immunoassay analysers; genetic testing apparatus for medical purposes; body composition analyzers for medical purposes; probes for medical purposes; analysers for bacterial identification for medical purposes; medical diagnostic testing instruments for use in immunoassay procedure; surgical apparatus and instruments; blood testing apparatus; apparatus for use in medica...
surelite

General Information


Serial Number79388704
Word MarkSURELITE
Filing DateFriday, November 17, 2023
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, February 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkSURE LITE
Goods and ServicesImmunochemical testing apparatus for medical use; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical diagnostic apparatus for testing blood sugar levels, cancer cells, dna and rna, antigen and antibody levels, hormones and metabolites and viruse; apparatus for DNA and RNA testing for medical purposes; analysers for medical use, namely, blood immunoassay analysers, enzyme immunoassay analysers; genetic testing apparatus for medical purposes; body composition analyzers for medical purposes; probes for medical purposes; analysers for bacterial identification for medical purposes; medical diagnostic testing instruments for use in immunoassay procedure; surgical apparatus and instruments; blood testing apparatus; apparatus for use in medical analysis, namely, blood immunoassay analysers, enzyme immunoassay analysers; radiotherapy apparatus; physiotherapy apparatus, namely, body rehabilitation apparatus for medical use; X-ray apparatus for medical purposes; lasers for medical purposes; sanitary masks; protective gowns for medical use; gloves for medical purposes; hearing aids; artificial limbs; orthopaedic belts; orthopaedic bandages; orthopaedic footwear; suture materials

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, February 21, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSansure Biotech Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Tuesday, February 27, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, February 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 13, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, February 9, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB